Woodline Partners’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Woodline Partners’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,192,177	Closed	-$34.2M	–	809
2023 Q1	$34.2M	Buy	1,192,177 +197,048	+20%	+$5.84M	0.46%	58
2022 Q4	$31M	Buy	995,129 +511,385	+106%	+$16.7M	0.42%	55
2022 Q3	$9.8M	Sell	483,744 -153,243	-24%	-$2.79M	0.14%	201
2022 Q2	$9.9M	Sell	636,987 -12,166	-2%	-$209K	0.15%	178
2022 Q1	$12.4M	Buy	649,153 +399,104	+160%	+$7.12M	0.2%	153
2021 Q4	$6.33M	Sell	250,049 -9	-0%	-$264	0.09%	257
2021 Q3	$8.19M	Buy	+250,058	New	+$8.52M	0.13%	183

Other funds holding DICE

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $10.2B AUM 0.67% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Woodline Partners's DICE Position: Q2 2023 in Review

Woodline Partners sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q2 2023, closing a stake of 1,192,177 shares — an estimated $34.2M sold.

Woodline Partners first reported a position in DICE in Q3 2021 and held it in 7 quarters. The position peaked at $34.2M in Q1 2023. 160 funds tracked by Wall St. Rank hold DICE as of Q2 2023.

Woodline Partners reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Woodline Partners sold 1,192,177 DICE Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $34.2M.
Woodline Partners first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
Woodline Partners's DICE Therapeutics, Inc. Common Stock position peaked at $34.2M in Q1 2023.
160 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Woodline Partners's 13F filing for Q2 2023, filed 14 Aug 2023.